ReWalk Announces Collaboration With Harvard University's Wyss Institute To Develop Lightweight And Soft Exoskeleton Systems For The Treatment Of Stroke, Multiple Sclerosis And Limited Mobility Patients

ReWalk Robotics Ltd. (Nasdaq:RWLK) ("ReWalk" or "Company"), the leading global exoskeleton developer and manufacturer today announceda collaboration withHarvard University'sWyss Institute for Biologically Inspired Engineering for the licensing of Intellectual Property (IP), and development of concepts and designs of lightweight exoskeleton system technologies for lower limb disabilities.
Source: Medical Design Online News - Category: Medical Equipment Source Type: news